Bill116th CongressFiled Mar 5, 2019Health
S. 660
Efficiency and Transparency in Petitions Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Mar 5, 2019)
Efficiency and Transparency in Petitions Act
This bill requires a petition regarding a pending generic drug or biological product application to be submitted to the Food and Drug Administration (FDA)within one year of when the petitioner discovers the issue that is the basis for the petition.
The FDA may grant a waiver of the one-year deadline.
What just happenedMar 5, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Braun, Mike [R-IN](R-IN)Sponsor
1committees2actions4subjects
- Introduced in SenateMar 5, 2019
- Mar 5, 2019IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Mar 5, 2019IntroReferral10000
Introduced in Senate